# Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.

> **NCT05458973** · — · UNKNOWN · sponsor: **Yonsei University** · enrollment: 100 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05458973
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-31
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05458973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05458973, "Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05458973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*